Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
OneroRx has completed its acquisition of NuCara Specialty Pharmacy as an add-on transaction. The deal is described as involving NuCara pharmacy locations, with no purchase price or other financial terms disclosed.
NuCara operates and manages more than 30 full-service, community-based pharmacies across Iowa, Texas, North Dakota, and Minnesota. The broader business context in the coverage also references a state lawsuit involving NuCara’s alleged $22 million owed for an HIV treatment program and the company’s management involvement of Iowa Rep. Brett Barker as vice president of operations.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026